Viewing Study NCT00522795


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-02-01 @ 10:15 PM
Study NCT ID: NCT00522795
Status: COMPLETED
Last Update Posted: 2020-02-17
First Post: 2007-08-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
Sponsor: Brown University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: BrUOG-E-215
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View